Family Medicine · Alexandria, LA
NPI
1063402667
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1587 N Bolton Ave, Suite 1100
Alexandria, LA, 71303
Phone (318) 473-4500
Groups this clinician bills Medicare through
Medicare paid, 2024
$428K
14,963 services
Medicare patients, 2024
722
Average age 74
Drug cost, 2024
$1.7M
14,317 prescriptions
Company payments, 2025
$1,154
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael G Buck was code 36415 (venipuncture blood collection), 1,421 times for 605 patients. In total Michael G Buck billed 14,963 services in 125 codes, and Medicare paid $428K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,421 | 605 | $8.60 | $12K |
| 80053 Clinical Chemistry | Office | 1,330 | 603 | $10.30 | $14K |
| 83735 Clinical Chemistry | Office | 1,297 | 599 | $6.53 | $8,470 |
| 80061 Clinical Chemistry | Office | 1,239 | 597 | $13.00 | $16K |
| 99213 Office E&M - Established | Office | 1,046 | 468 | $58.33 | $61K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 900 | 506 | $11.21 | $10K |
| 85025 Blood Count | Office | 819 | 559 | $7.59 | $6,219 |
| 83036 Blood Count | Office | 812 | 413 | $9.45 | $7,670 |
| 84443 Clinical Chemistry | Office | 779 | 546 | $16.43 | $13K |
| 99214 Office E&M - Established | Office | 614 | 556 | $75.74 | $47K |
| 81003 Clinical Chemistry | Office | 589 | 512 | $2.18 | $1,286 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 391 | 391 | $124.03 | $48K |
| 82043 Clinical Chemistry | Office | 259 | 255 | $5.62 | $1,456 |
| 82570 Clinical Chemistry | Office | 255 | 252 | $5.04 | $1,286 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 233 | 33 | $0.73 | $170 |
By year: 2022 $378K for 13,099 services; 2023 $378K for 13,907 services; 2024 $428K for 14,963 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,421 | 605 | $8.60 | $12K |
| 80053 Clinical Chemistry | 1,330 | 603 | $10.30 | $14K |
| 83735 Clinical Chemistry | 1,297 | 599 | $6.53 | $8,470 |
| 80061 Clinical Chemistry | 1,239 | 597 | $13.00 | $16K |
| 85025 Blood Count | 819 | 559 | $7.59 | $6,219 |
| 83036 Blood Count | 812 | 413 | $9.45 | $7,670 |
| 84443 Clinical Chemistry | 779 | 546 | $16.43 | $13K |
| 81003 Clinical Chemistry | 589 | 512 | $2.18 | $1,286 |
| 82043 Clinical Chemistry | 259 | 255 | $5.62 | $1,456 |
| 82570 Clinical Chemistry | 255 | 252 | $5.04 | $1,286 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael G Buck prescribed most often to Medicare patients was Atorvastatin Calcium, with 621 prescriptions and refills. In total Michael G Buck wrote 14,317 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 621 | 1,688 | 205 | $9,356 |
| Levothyroxine Sodium Generic | 491 | 1,225 | 131 | $4,322 |
| Amlodipine Besylate Generic | 420 | 1,169 | 142 | $3,401 |
| Carvedilol Generic | 407 | 1,042 | 127 | $4,109 |
| Hydrochlorothiazide Generic | 378 | 1,039 | 133 | $925 |
| Omeprazole Generic | 370 | 928 | 127 | $5,019 |
| Losartan Potassium Generic | 359 | 903 | 103 | $5,468 |
| Metformin Hcl Er Metformin Hcl | 276 | 702 | 88 | $3,004 |
| Pravastatin Sodium Generic | 260 | 679 | 89 | $4,245 |
| Trazodone Hcl Generic | 246 | 622 | 81 | $3,464 |
| Gabapentin Generic | 224 | 448 | 76 | $2,829 |
| Tamsulosin Hcl Generic | 214 | 534 | 71 | $2,950 |
| Mounjaro Tirzepatide | 214 | 255 | 36 | $265K |
| Ezetimibe Generic | 213 | 580 | 74 | $8,015 |
| Potassium Chloride Generic | 209 | 469 | 60 | $4,276 |
Brand drugs: 2,053 claims; generic drugs: 12,170 claims; opioid claims: 303.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael G Buck $1,154 ($1,154 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $319.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $319 |
| Abbvie Inc. ABBV | 16 | $237 |
| Lilly USA, LLC LLY | 12 | $145 |
| Novo Nordisk Inc NVO | 6 | $99.89 |
| Pfizer Inc. PFE | 3 | $79.41 |
| GlaxoSmithKline, LLC. GSK | 4 | $70.11 |
| Xeris Pharmaceuticals, Inc. | 2 | $33.6 |
| Averitas Pharma Inc. | 1 | $22.42 |
| Aucta Pharmaceuticals, Inc. | 1 | $19.73 |
| Seqirus USA Inc CSL.AX | 1 | $19.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.